Form 4: TRON director Christopher Melton reports 15,000-share sale

Rhea-AI Filing Summary

Tron Inc. director Christopher Melton reported a sale of 15,000 shares of Tron Inc. common stock on 08/22/2025 at a reported price of $5.06 per share. After the transaction he beneficially owned 31,818 shares. The Form 4 is signed and dated 08/28/2025.

Positive

• Timely disclosure of the insider sale with a signed Form 4
• Clear transaction details: number of shares, price, and post-sale beneficial ownership provided

Negative

• Insider sold 15,000 shares, reducing direct ownership to 31,818 shares
• No information provided on whether the sale was part of a prearranged trading plan

Insights

Financial Analyst

TL;DR Director sold shares; transaction appears routine and does not by itself indicate a material change to company fundamentals.

The Form 4 discloses a direct sale of 15,000 common shares at $5.06, leaving the director with 31,818 shares. The size of the sale relative to total outstanding shares is not provided, so investor impact cannot be fully assessed from this filing alone. Timing and price are explicit; there is no accompanying commentary on a trading plan or reason for the sale in the filing.

Corporate Governance Expert

TL;DR Insider reported a standard Section 16 disclosure; documentation and signature are present, meeting Form 4 filing requirements.

The filing identifies Christopher Melton as a director and shows a disclosed sale transaction with signature. The form indicates the filing was by one reporting person and includes the required signature and dates. There is no amendment noted and no 10b5-1 plan disclosure box checked, so the filing provides only the basic required transparency.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Melton Christopher

(Last) (First) (Middle)

C/O TRON INC.

941 W. MORSE BLVD. SUITE 100

(Street)

WINTER PARK FL 32789

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Tron Inc. [ TRON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/22/2025		S		15,000	D	$5.06	31,818	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Christopher Melton	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Tron Inc. (TRON) director Christopher Melton report on Form 4?

He reported a sale of 15,000 shares of Tron Inc. common stock on 08/22/2025 at $5.06 per share, leaving 31,818 shares beneficially owned.

When was the Form 4 signed and filed for the TRON insider transaction?

The Form 4 bears the reporting person's signature dated 08/28/2025 and lists the transaction date as 08/22/2025.

Does the Form 4 indicate Christopher Melton is an officer or a director of TRON?

The filing indicates Christopher Melton's relationship to the issuer as a Director.

Was the insider sale of TRON shares reported as part of a 10b5-1 trading plan?

No; the form does not indicate that the transaction was made pursuant to a 10b5-1(c) trading plan.

How many shares does Christopher Melton own after the reported sale?

Following the reported transaction he beneficially owned 31,818 shares.